Update in ITP and TTP (R2P SPOC)

Originally presented February 24, 2021 as part of the UNC Lineberger Cancer Network Research to Practice Lecture Series. Course expires April 13, 2022.

Presenter

Photo of Alice Ma, MD, FACP

Alice Ma, MD, FACP
The Medical Alumni Loyalty Fund Distinguished Teaching Professor
Director, Division of Hematology Fellowship
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Update in ITP and TTP

Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura are both autoimmune conditions leading to low platelets, though the mechanism by which the platelets are consumed differs.  The lecture will update viewers on new therapies for the treatment of ITP and TTP

Learning Objectives

  • Explain the role of thrombopoietin receptor agonists in the treatment of ITP
  • Discuss the role of caplacizumab in the treatment of TTP
  • Describe the optimal prophylaxis and immunizations for patients treated with prolonged corticosteroids or other immunosuppressants for ITP and TTP

Credits Offered

  • 1.0 ANCC (NCPD/CNE) hours of study.
  • 1 ASRT Category A CE Credit
  • 1.0 AMA PRA Category 1 Credit
  • 1.0 ACPE CE Credit
  • General Participation

Requirements

To receive credit for this course, you must:

  • Watch a lecture video recording.
  • Complete the lecture post test and obtain a passing score of 80% or higher.
  • Complete the course evaluation.
  • Select credit type.

Estimated course completion time: 1 hour

Disclosures

This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. William A Wood, MD, MPH, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.

Alice Ma, MD, FACP, has no relevant financial relationships with commercial interests as defined by the ACCME.

Accreditation

The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Approved by the UNC Eshelman School of Pharmacy for ACPE.

Approved by the American Society of Radiologic Technologists (ASRT).

The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.